Yutaka Kanda

The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity

Toyohide Shinkawa, Kazuyasu Nakamura, Naoko Yamane et al. · Journal of Biological Chemistry · 2003 · 1.4K citations · Full text

Life Sciences, Biochemistry, Immunology +17

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

Yutaka Kanda, Tsuyoshi Yamada, Katsuhiro Mori et al. · Glycobiology · 2006 · 375 citations

Pharmacy, Biochemistry, Immunology +17

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA

Katsuhiro Mori, Reiko Kuni‐Kamochi, Naoko Yamane‐Ohnuki et al. · Biotechnology and Bioengineering · 2004 · 174 citations

Life Sciences, Biotechnology, Molecular Biology +17

Total synthesis of (+)-leinamycin

Yutaka Kanda, Tohru Fukuyama · Journal of the American Chemical Society · 1993 · 141 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7

KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation

Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa et al. · Blood · 2009 · 130 citations · Full text

Medicine, Oncology, Pharmacology +14